Page last updated: 2024-08-25

n-leucyldoxorubicin and Breast Neoplasms

n-leucyldoxorubicin has been researched along with Breast Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bennis, S; Garcia, C; Robert, J1
Berger, DP; Breistøl, K; Fiebig, HH; Fodstad, O; Hendriks, HR; Langdon, SP1
Abarca-Quinones, J; Baurain, R; Dubois, V; Fernandez, AM; Lobl, TJ; Oliyai, C; Passioukov, A; Shochat, D; Trouet, A; Van derpoorten, K1

Other Studies

3 other study(ies) available for n-leucyldoxorubicin and Breast Neoplasms

ArticleYear
Aspects of the cellular pharmacology of N-l-leucyldoxorubicin in human tumor cell lines.
    Biochemical pharmacology, 1993, May-05, Volume: 45, Issue:9

    Topics: Breast Neoplasms; Cell Death; Doxorubicin; Drug Resistance; Humans; Leukemia; Prodrugs; Time Factors; Tumor Cells, Cultured

1993
The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts.
    European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:10

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Division; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Prodrugs; Transplantation, Heterologous

1998
Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer: application to doxorubicin and preliminary in vitro and in vivo studies.
    Cancer research, 2001, Apr-01, Volume: 61, Issue:7

    Topics: Animals; Antibiotics, Antineoplastic; Biotransformation; Breast Neoplasms; Doxorubicin; Drug Stability; Female; Humans; Lethal Dose 50; Male; Mice; Mice, Inbred BALB C; Oligopeptides; Prodrugs; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2001
chemdatabank.com